In-vitro process for quick determination of the status of an infection with an influenza virus type

The novel test system can discriminate T cell immunity induced by an acute encounter of influenza viruses from lasting T cell immunity after earlier infections or preceding vaccinations. The test system can be performed out of whole blood, following a multi-dimensional T cell immunomonitoring of cytokine profiles after specific antigen stimulation with a processing time of 8 hours.

Further Information: PDF

Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/302-71302

Contact
Dipl.-Kfm. Axel Koch (MBA), Dr. Conny Clausen, Dr. Hauke Studier, Dr. Susanne Heiligenstein

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Cooling down solar cells, naturally

Photovoltaics are more efficient when they operate at lower temperatures, which can be achieved in solar farms that space out arrays and use the wind to their advantage. A bright,…

Strongest Arctic cyclone on record led to surprising loss of sea ice

A warming climate is causing a decline in sea ice in the Arctic Ocean, where loss of sea ice has important ecological, economic and climate impacts. On top of this…

Tuberculosis and COVID-19 lung lesions

… revealed by high-resolution three-dimensional imaging. Insights that are not possible with conventional two-dimensional platforms include characterization of obliterated airways in tuberculosis and hemorrhage from ruptured blood vessels in COVID-19…

Partners & Sponsors